Laura Prendergast
Stock Analyst at Stifel Nicolaus
(4.64)
# 877
Out of 5,010 analysts
84
Total ratings
50.7%
Success rate
31.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Reiterated: Buy | $48 → $30 | $8.54 | +251.29% | 2 | Sep 14, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $230 | $204.48 | +12.48% | 23 | Sep 13, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $23 → $15 | $3.92 | +282.65% | 5 | Sep 9, 2026 | |
| ERAS Erasca | Reiterated: Buy | $30 | $14.21 | +111.12% | 12 | Aug 17, 2026 | |
| FHTX Foghorn Therapeutics | Reiterated: Buy | $12 | $3.52 | +240.91% | 7 | Aug 17, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $48 | $16.10 | +198.14% | 2 | Aug 17, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $40 | $24.42 | +63.80% | 10 | Aug 17, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $8 | $1.87 | +327.81% | 7 | Aug 6, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $14 | $13.37 | +4.71% | 2 | Aug 4, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $45 | $31.66 | +42.14% | 9 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $10.55 | n/a | 3 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $8.94 | n/a | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 | $2.62 | n/a | 1 | Aug 14, 2024 |
Olema Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $48 → $30
Current: $8.54
Upside: +251.29%
Revolution Medicines
Sep 13, 2026
Reiterated: Buy
Price Target: $230
Current: $204.48
Upside: +12.48%
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $23 → $15
Current: $3.92
Upside: +282.65%
Erasca
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $14.21
Upside: +111.12%
Foghorn Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $3.52
Upside: +240.91%
Sutro Biopharma
Aug 17, 2026
Reiterated: Buy
Price Target: $48
Current: $16.10
Upside: +198.14%
Tango Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $40
Current: $24.42
Upside: +63.80%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $1.87
Upside: +327.81%
ORIC Pharmaceuticals
Aug 4, 2026
Reiterated: Buy
Price Target: $14
Current: $13.37
Upside: +4.71%
Cogent Biosciences
Jun 15, 2026
Reiterated: Buy
Price Target: $45
Current: $31.66
Upside: +42.14%
Jul 29, 2025
Reiterated: Buy
Price Target: $12
Current: $10.55
Upside: n/a
Feb 13, 2025
Reiterated: Buy
Price Target: $4
Current: $8.94
Upside: n/a
Aug 14, 2024
Upgraded: Buy
Price Target: $16
Current: $2.62
Upside: n/a